The 4 Mayo – Sheba Cardiovascular Symposium new new.pdf · Sheba Medical Center p 2 c Rnd SR RgRT...
Transcript of The 4 Mayo – Sheba Cardiovascular Symposium new new.pdf · Sheba Medical Center p 2 c Rnd SR RgRT...
The 4th Mayo – Sheba Cardiovascular Symposium25th March 2018
Sheba Medical Center
p
SymposiumCardiacShebaMayond2ApproachBasedCase–CardiologyinFrontiersNew
SundayDecember9th,HeartCenterAuditorium
09:00 – 09:30 Welcomeandopeningremarksandreviewofthecollaborativeproject ZeevRotstein MichaelEldar MichaelGlikson AmirLerman09:30 – 11:00 SessionICaseBasedClinicalUpdates The pericardium – no more Terra Incognita for the electrophysiologist SamAsirvatham Acute coronary syndrome in women : case based approach AmirLerman Update on Cardiac Rehabilitation – The gold standard for CVD secondary prevention therapy? RandallThomas11:00 - 11:30 Coffee Break 11:30 – 12:30 SessionIIClinicalandbasicUpdates Bone marrow-based cell therapy for CV disease. RobertSimari Assessment of severity of aortic stenosis JaeKOh12:30-14:00 SessionIII-Collaborativeresearchupdate The raise CRT trial MichaelGlikson New echo parameter for CRT JaeKOh Endothelial dysfunction in clinical practice AmirLerman Resident vascular progenitor cells. RobertSimari Exercise training in AF patients RandallThomas 14:00 – 15:00 Lunch Buffet 15:00 – 16:30 Businessmeetingofresearchgroups 17:00 Reception 18:30 Adjournment
requiredregistrationAdvance[email protected]:email,www.sheba.co.il:Registration
09:00 – 09:30 Welcomeandopeningremarksandreviewofthecollaborativeproject ZeevRotstein MichaelEldar MichaelGlikson AmirLerman09:30 – 11:00 SessionICaseBasedClinicalUpdates The pericardium – no more Terra Incognita for the electrophysiologist PaulFriedman Acute coronary syndrome in women : case based approach AmirLerman Update on Cardiac Rehabilitation – The gold standard for CVD secondary prevention therapy? RandallThomas11:00 - 11:30 Coffee Break 11:30 – 12:30 SessionIIClinicalandbasicUpdates Bone marrow-based cell therapy for CV disease. RobertSimari Assessment of severity of aortic stenosis JaeKOh12:30-14:00 SessionIII-Collaborativeresearchupdate The raise CRT trial MichaelGlikson New echo parameter for CRT JaeKOh Endothelial dysfunction in clinical practice AmirLerman Resident vascular progenitor cells. RobertSimari Exercise training in AF patients RandallThomas 14:00 – 15:00 Lunch Buffet
requiredregistrationAdvance[email protected]:email,www.sheba.co.il:Registration
The C
haim
She
ba M
edical Center at Tel Hashomer l Est. 1948
The Hospital of Israel
Mackram Eleid - Structural and Ischemic Heart Disease
Steve Ommen - Hypertrophic Cardiomyopathy
Kyle Klarych - Hypertrophic Cardiomyopathy
Amir Lerman - Coronary Physiology
Paul Friedman - Electrophysiology
Hartzell Schaff – CV Surgery
Sudhir Kushwaha - Cardiac Transplant/Heart Failure
Rihal S. Charanjit - Chair, Division of Cardiovascular Diseases
8:00 – 8:30 Registration and coffee
8:30 – 8:45 Welcome (Kreiss, Raanani, Segev,
Glikson)
8:45 – 9:00 Brief review of the Mayo Sheba
Collaboration (Glikson + Lerman)
9:00 - 9:30 Progress report of three
Collaborative Mayo – Sheba
studies (Glikson , Shechter , Leor)
9:30 - 11:00 Session I – HCMP overview
9:30 – 9:35 Welcome by Dr Daniel Monakier,
Chair, Israeli Heart Society
Cardiomyopathy working group
9:35 – 9:55 Variants and differential diagnosis
of HCMP (Klarych)
9:55 - 10:15 The role of genetic testing in
HCMP (Arad)
10:15-10:35 Noise & Order: Maintenance and
growth of cardiac sarcomeres
(Kehat)
10:35-10:55 Understanding HCMP and current
knowledge gaps (Ommen)
10:55-11:15 Coronary pathophysiology in
HOCM (Lerman)
11:15-11:30 Q&A
11:30-12:00 Coffee break
12:00–13:30 Session II - Treatment of HCMP
12:00–12:15 Treatment according to ESC
and ACC guidelines for HCMP
– similarities and differences
(Ommen)
12:15-12:30 Surgical treatment of HOCM in 2017
– an overview (Schaff)
12:30-12:45 Catheter based septal ablation –
an overview (Eleid)
12:45-13:00 Septal Myectomy, Sheba
experience- (Raanani)
13:00-13:15 What is the risk of SCD following
septal ablation and following
myectomy? (Friedman)
13:15-13:30 Septal ablation vs myectomy –
Case – based discussion:
Moderator: Ommen
Discussants: Schaff, Eleid
13:30-14:30 Lunch
14:30-16:00 Session III
14:30-14:50 Current role of imaging in HCMP
(Klarych)
14:50-15:10 Risk stratification and prevention
of sudden death in HCMP
(Friedman)
15:10-15:30 Systolic and diastolic heart failure
in HCMP (Kushwaha)
15:30-15:50 The mitral valve in HCMP –
mechanism and evaluation
(Kuperstein)
15:50-16:00 Q&A
Sunday March 25th 2018
Please be advised that due to limited seating in the auditoriumregistration is required.
Contact for registration:Marketing department, Sheba Medical Center
E-mail: [email protected]: +972-3-5305000, choose line 0 and then line 2, 8:00-16:00
ENTRANCE IS FREE